Stefania I Papatheodorou1, Hannah Buettner2, Mary B Rice3, Murray A Mittleman4. 1. Cyprus International Institute for Environmental and Public Health in association with the Harvard T. H. Chan School of Public Health, Limassol, Cyprus. Electronic address: s.papatheodorou@cut.ac.cy. 2. Tufts University School of Medicine, Boston, MA. 3. Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, MA; Division of Pulmonary, Critical Care and Sleep Medicine, Beth Israel Deaconess Medical Center, Boston, MA. 4. Cardiovascular Epidemiology Research Unit, Beth Israel Deaconess Medical Center, Boston, MA.
Abstract
BACKGROUND: The medical and recreational use of marijuana is now legal in some parts of the United States; the health effects are unknown. We aimed to evaluate associations between recent marijuana use and exhaled nitric oxide (eNO) and pulmonary function. METHODS: We performed a cross-sectional study of 10,327 US adults participating in the National Health and Nutrition Examination Survey in the years 2007 to 2012. We examined associations between marijuana use and eNO, FEV1, FVC, the FEV1/FVC ratio, and forced expiratory flow (midexpiratory phase) (FEF25%-75%) by weighted linear regression. RESULTS: In the study population, there were 4,797 never users, 4,084 past marijuana users, 555 participants who used marijuana 5 to 30 days before the examination, and 891 participants who used marijuana 0 to 4 days before the examination. Current marijuana use in the past 4 days was associated with 13% lower eNO (95% CI, -18% to 8%). FVC was higher in past users (75 mL; 95% CI, 38-112) and current users in the past 5 to 30 days (159 mL; 95% CI, 80-237) and in users within 0 to 4 days of the examination (204 mL; 95% CI, 139-270) compared with never users. All associations remained unchanged and statistically significant in sensitivity analyses excluding current and past tobacco users. CONCLUSIONS: Current marijuana use was associated with lower levels of eNO and higher FVC. The lower eNO in marijuana smokers suggests that short-term exposure to marijuana may, like tobacco, acutely affect the pulmonary vascular endothelium and impair airflow through the small airways.
BACKGROUND: The medical and recreational use of marijuana is now legal in some parts of the United States; the health effects are unknown. We aimed to evaluate associations between recent marijuana use and exhaled nitric oxide (eNO) and pulmonary function. METHODS: We performed a cross-sectional study of 10,327 US adults participating in the National Health and Nutrition Examination Survey in the years 2007 to 2012. We examined associations between marijuana use and eNO, FEV1, FVC, the FEV1/FVC ratio, and forced expiratory flow (midexpiratory phase) (FEF25%-75%) by weighted linear regression. RESULTS: In the study population, there were 4,797 never users, 4,084 past marijuana users, 555 participants who used marijuana 5 to 30 days before the examination, and 891 participants who used marijuana 0 to 4 days before the examination. Current marijuana use in the past 4 days was associated with 13% lower eNO (95% CI, -18% to 8%). FVC was higher in past users (75 mL; 95% CI, 38-112) and current users in the past 5 to 30 days (159 mL; 95% CI, 80-237) and in users within 0 to 4 days of the examination (204 mL; 95% CI, 139-270) compared with never users. All associations remained unchanged and statistically significant in sensitivity analyses excluding current and past tobacco users. CONCLUSIONS: Current marijuana use was associated with lower levels of eNO and higher FVC. The lower eNO in marijuana smokers suggests that short-term exposure to marijuana may, like tobacco, acutely affect the pulmonary vascular endothelium and impair airflow through the small airways.
Authors: Donald P Tashkin; Gayle C Baldwin; Theodore Sarafian; Steven Dubinett; Michael D Roth Journal: J Clin Pharmacol Date: 2002-11 Impact factor: 3.126
Authors: Nicolas Rodondi; Mark James Pletcher; Kiang Liu; Stephen Benjamin Hulley; Stephen Sidney Journal: Am J Cardiol Date: 2006-06-19 Impact factor: 2.778
Authors: Rachel Nadif; Regis Matran; Jean Maccario; Magali Bechet; Nicole Le Moual; Pierre Scheinmann; Jean Bousquet; Francine Kauffmann; Isabelle Pin Journal: Ann Allergy Asthma Immunol Date: 2010-05 Impact factor: 6.347
Authors: Jeffrey C Hoyt; Richard A Robbins; Michael Habib; David R Springall; Lee D K Buttery; Julia M Polak; Peter J Barnes Journal: Exp Lung Res Date: 2003 Jan-Feb Impact factor: 2.459
Authors: Bess M Flashner; Sheryl L Rifas-Shiman; Emily Oken; Carlos A Camargo; Thomas J Platts-Mills; Lisa Workman; Augusto A Litonjua; Diane R Gold; Mary B Rice Journal: Pediatr Pulmonol Date: 2019-12-05